Doctors continue fight against Covid as number of virus deaths at Northampton General Hospital nears 1,000

Life-saving medication offered to most vulnerable patients who test positive
Watch more of our videos on Shots! 
and live on Freeview channel 276
Visit Shots! now

Specialist hospital teams are continuing the fight against Covid-19 by offering potentially life-saving medication to some the most vulnerable people in Northamptonshire.

Staff at Northampton General Hospital have provided treatments, either as tablets or intravenous infusions, as part of a national network of Covid Medicines Delivery Units (CDMUs) set up in December 2021.

Hide Ad
Hide Ad

The county’s CMDU triage hub at NGH screens and contacts Covid-positive patients with underlying health conditions and is run by a dedicated team of four urgent care physician associates — qualified healthcare professionals working alongside doctors — prescribing antivirals or neutralising monoclonal antibody medications.

Physician associates in the Covid Medicines Delivery Unit team are helping deliver potentially life-saving drugs to vulnerable patients at Northampton General HospitalPhysician associates in the Covid Medicines Delivery Unit team are helping deliver potentially life-saving drugs to vulnerable patients at Northampton General Hospital
Physician associates in the Covid Medicines Delivery Unit team are helping deliver potentially life-saving drugs to vulnerable patients at Northampton General Hospital

NGH clinical director for urgent care, Dr Tristan Dyer, oversees the CMDU. He said: “Our team of physician associates were asked to very rapidly set up a CMDU for Northamptonshire in December and they have done an amazing job.

“Since we launched the service they have contacted over 4,000 patients with Covid-19 and offered these treatments to patients who were not improving and were suitable for treatment.

“Where patients have needed to come to hospital for IV infusions of monoclonal antibodies they have also delivered many of the treatments.”

Hide Ad
Hide Ad

Underlying health conditions can include people with multiple sclerosis, motor neurone disease, cancer, kidney or liver disease, immune deficiencies, or patients taking long-term immune system suppressing medications for certain conditions.

Having these conditions puts patients at greater risk from Covid-19 but the specialist treatments are known to be up to 89 percent effective at preventing more serious illness and hospitalisation if taken within seven days of onset of symptoms.

Despite a fall in reported Covid cases recently, latest NHS England figures revealed 18 Covid patients died in Northamptonshire’s two main NHS hospitals in the week to Wednesday (August 17) — the highest weekly number since April.

At NGH, official figures show 986 Covid patients have sadly died since the pandemic began in March 2020 while KGH has seen another 767 deaths. More than 300 of the 1,753 total deaths have occurred this year.

Hide Ad
Hide Ad

A Physician Associates spokesman added: “Vaccination offers a degree of protection for patient in high-risk groups but they still remain vulnerable, in particular to new Covid-19 variants.

“Many of the highest risk patients will have received a letter from the NHS telling them they may be eligible for these treatments in the event they test positive.

“They will receive PCR or LFT tests to keep at home in case they develop symptoms and if they test positive they are asked to upload results onto the gov.uk website.

“Positive patients are then flagged electronically to our team at NGH.

Hide Ad
Hide Ad
Read More
Northamptonshire care home rated inadequate for third consecutive time

“We call all patients to assess how they are coping with Covid and if they are not improving, and they are within seven-days of onset of symptoms, we may offer them antivirals or neutralising monoclonal antibody treatment.

“Depending on their condition and the medications they are on, that will mean a relative picking up oral tablets from the hospital pharmacy at either Northampton or Kettering general hospitals or going into those hospitals to have an intravenous infusion in dedicated rooms.”